People

Donald Nicholson

Donald Nicholson, published by Atlas as Don Nicholson, is an Atlas adviser and former CEO of Nimbus Therapeutics. His own Atlas biography and Muna board biography describe 25 years at Merck and research into apoptotic cell death. He earned a biochemistry PhD at Western Ontario and completed postdoctoral training in Munich. The current Atlas card names an executive-chair role at Disc; company governance is separate from Atlas fund employment.